Robert Olstein
Olstein Capital Management
Robert Olstein NUTRACEUTICAL INTL CORP stake
total: 342
Olstein Capital Management NUTR trades
- Total transactions:
- 6
- New positions:
- 1
- Sold out:
- 1
- Added:
- 4
- Held since:
- 2013 Q4
- Held for:
- 5 quarters
- Latest activity:
- 2015 Q1
According to 2026 Q2 report, Robert Olstein doesn't hold any NUTRACEUTICAL INTL CORP (NUTR) shares. To date, the estimated cost basis is nearly $24.69 for "buy" trades and estimated average "sell" price is $21.57. Olstein Capital Management first purchased NUTR in 2013 Q4, initially acquiring 2,100 shares. Since the initial investment in NUTRACEUTICAL INTL CORP (NUTR), Olstein Capital Management has made 5 more transactions.
When did Robert Olstein sell NUTRACEUTICAL INTL CORP (NUTR)?
Robert Olstein sold off the entire NUTRACEUTICAL INTL CORP (NUTR) position in 2015 Q1.
When did Robert Olstein buy NUTRACEUTICAL INTL CORP (NUTR)?
Robert Olstein first invested in NUTRACEUTICAL INTL CORP (NUTR) in 2013 Q4 at the reported quarter-end price of $26.67 per share.
What's the cost basis of Olstein Capital Management's NUTR stake?
The estimated cost basis for NUTRACEUTICAL INTL CORP (NUTR) stake is around $24.69 per share. This represents their average reported price* across all buy transactions
Estimated cost basis*
- Weighted AVG buy price:
- $24.69
- Weighted AVG sell price:
- $21.56
Robert Olstein's historical trades in NUTRACEUTICAL INTL CORP
6 results
| Period |
% of portfolio |
Shares held after* |
Reported price* |
Value* |
% (shares) of activity |
% change to portfolio |
|---|---|---|---|---|---|---|
|
2015 Q1
|
0.00%
|
$21.56
|
-100% (-85,000)
|
|||
|
2014 Q4
|
0.22%
|
$21.56
|
+10.39% (+8,000)
|
|||
|
2014 Q3
|
0.21%
|
$20.91
|
+8.45% (+6,000)
|
|||
|
2014 Q2
|
0.23%
|
$23.86
|
+44.90% (+22,000)
|
|||
|
2014 Q1
|
0.17%
|
$26.00
|
+2,233.33% (+46,900)
|
|||
|
2013 Q4
|
0.01%
|
$26.67
|
new
|
|||
* Shares, change to shares, sold shares, shares held after: split-adjusted.
* Reported price: this doesn't represent the actual buy or sell price. It is the split-adjusted price of the security as of the last day of the reported period.
If the security is completely sold out, we show the reported split-adjusted price prior to the actual period.
If the security is completely sold out, we show the reported split-adjusted price prior to the actual period.
* Estimated cost basis: based on "Reported price*" (not earlier than 2013 Q2). Calculation starts from the latest "new buy" activity to the latest "close out" activity (if any).
* Value or Price: If the security is completely sold out, we show the reported value (or price) prior to the actual period.
* New buy or own: this means there is no earlier reporting (for us or in general). So we can't know if the actual purchase of the security happened at the reported period or earlier.